OnKure Therapeutics Inc (Class A) Live Stock Price Today, Share Analysis and Chart

Name: OnKure Therapeutics Inc. - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: OnKure Therapeutics Inc. - Ordinary Shares - Class A
Rating: 2.16441675
Author: Trendlyne DVM scores

about

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-bas...

4.19 -0.19 (-4.34%)

146.47% Gain from 52W Low

388.8K

XNAS Volume

XNAS 20 Mar, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

13.7 / 100

Technically Bullish

72.9 / 100

No estimates available

OnKure Therapeutics Inc (Class A) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

OnKure Therapeutics Inc (Class A) Live Stock Price Today, Share Analysis and Chart

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-bas...

146.47% Gain from 52W Low

SWOT Analysis

OnKure Therapeutics Inc (Class A) Live Price Chart